$1.87 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 100 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LVS | New | LAS VEGAS SANDS CORP | $39,743,514 | – | 685,233 | +100.0% | 2.12% | – |
| NVDA | New | NVIDIA CORPORATION | $32,780,666 | – | 77,492 | +100.0% | 1.75% | – |
| GPN | New | GLOBAL PMTS INC | $27,702,642 | – | 281,188 | +100.0% | 1.48% | – |
| RH | New | RH | $27,418,263 | – | 83,189 | +100.0% | 1.47% | – |
| TSM | New | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $23,921,169 | – | 237,031 | +100.0% | 1.28% | – |
| New | ZURA BIO LTD | $23,370,000 | – | 2,850,000 | +100.0% | 1.25% | – | |
| ACN | New | ACCENTURE PLC IRELAND | $21,632,384 | – | 70,103 | +100.0% | 1.16% | – |
| New | GENERAL ELECTRIC CO | $21,171,830 | – | 192,734 | +100.0% | 1.13% | – | |
| New | CANADIAN PACIFIC KANSAS CITY | $20,925,326 | – | 259,073 | +100.0% | 1.12% | – | |
| DFS | New | DISCOVER FINL SVCS | $18,819,394 | – | 161,056 | +100.0% | 1.01% | – |
| ATVI | New | ACTIVISION BLIZZARD INC | $17,465,948 | – | 207,188 | +100.0% | 0.93% | – |
| WWE | New | WORLD WRESTLING ENTMT INCcl a | $16,271,368 | – | 150,008 | +100.0% | 0.87% | – |
| CELH | New | CELSIUS HLDGS INC | $14,354,316 | – | 96,215 | +100.0% | 0.77% | – |
| EVR | New | EVERCORE INCclass a | $8,781,193 | – | 71,051 | +100.0% | 0.47% | – |
| GFL | New | GFL ENVIRONMENTAL INC | $3,855,750 | – | 99,375 | +100.0% | 0.21% | – |
| NRIX | New | NURIX THERAPEUTICS INC | $2,804,792 | – | 280,760 | +100.0% | 0.15% | – |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $2,241,170 | – | 81,143 | +100.0% | 0.12% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $693,762 | – | 6,058 | +100.0% | 0.04% | – |
| EW | New | EDWARDS LIFESCIENCES CORP | $216,959 | – | 2,300 | +100.0% | 0.01% | – |
| TECH | New | BIO-TECHNE CORP | $212,238 | – | 2,600 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ADOBE SYSTEMS INCORPORATED | 33 | Q4 2021 | 13.2% |
| AMAZON COM INC | 23 | Q2 2024 | 8.0% |
| UNITEDHEALTH GROUP INC | 23 | Q2 2024 | 5.7% |
| IQVIA HLDGS INC | 22 | Q2 2024 | 7.3% |
| CONSTELLATION BRANDS INC | 20 | Q4 2018 | 10.9% |
| META PLATFORMS INC | 19 | Q2 2024 | 10.9% |
| RESTAURANT BRANDS INTL INC | 18 | Q3 2019 | 8.9% |
| SUTRO BIOPHARMA INC | 18 | Q2 2024 | 1.9% |
| KALVISTA PHARMACEUTICALS INC | 18 | Q2 2024 | 1.8% |
| KEZAR LIFE SCIENCES INC | 18 | Q2 2024 | 1.4% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Erasca, Inc. | May 28, 2024 | 13,768,039 | 5.5% |
| ABEONA THERAPEUTICS INC. | May 13, 2024 | 3,685,503 | 9.3% |
| Benitec Biopharma Inc. | April 29, 2024 | 1,478,490 | 17.4% |
| Contineum Therapeutics, Inc. | April 15, 2024 | 1,720,000 | 9.3% |
| 89bio, Inc. | February 13, 2024 | 4,888,434 | 5.2% |
| Arcellx, Inc. | February 13, 2024 | 2,435,974 | 5.0% |
| Arcutis Biotherapeutics, Inc. | February 13, 2024 | 9,534,837 | 10.0% |
| Biohaven Ltd. | February 13, 2024 | 4,572,836 | 5.7% |
| EyePoint Pharmaceuticals, Inc. | February 13, 2024 | 4,774,389 | 10.0% |
| Fulcrum Therapeutics, Inc. | February 13, 2024 | 5,518,881 | 8.9% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| SC 13G | 2024-08-12 |
| SC 13G | 2024-05-28 |
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-05-13 |
| 3 | 2024-05-02 |
| SC 13D | 2024-04-29 |
| SC 13G | 2024-04-15 |
| 13F-HR | 2024-02-14 |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.